Tyra Biosciences Q4 EPS $(0.53) Misses $(0.48) Estimate
Portfolio Pulse from Happy Mohamed
Tyra Biosciences reported a Q4 EPS loss of $(0.53), missing the consensus estimate of $(0.48) by 10.42%, marking a 70.97% increase in losses from the same period last year.
March 19, 2024 | 8:12 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Tyra Biosciences reported a larger than expected Q4 loss, missing analyst estimates and showing a significant increase in losses compared to last year.
The reported earnings miss and the significant increase in losses year-over-year are likely to negatively impact investor sentiment and could lead to a short-term decrease in TYRA's stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100